BBNX
Beta Bionics, Inc.Company with tickers: BBNX
CIK
1674632
CUSIP
08659B102
Shares Outstanding
44,561,695
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $27,626,000 | USD | 2026-03-31 | 10-Q | 2026-04-21 |
| Cost of Revenue | — | ||||
| Gross Profit | $16,437,000 | USD | 2026-03-31 | 10-Q | 2026-04-21 |
| Operating Expenses | $40,708,000 | USD | 2026-03-31 | 10-Q | 2026-04-21 |
| Research & Development | $10,356,000 | USD | 2026-03-31 | 10-Q | 2026-04-21 |
| Operating Income | $-24,271,000 | USD | 2026-03-31 | 10-Q | 2026-04-21 |
| Net Income | $-21,895,000 | USD | 2026-03-31 | 10-Q | 2026-04-21 |
| EPS (Basic) | $-0.49 | USD/shares | 2026-03-31 | 10-Q | 2026-04-21 |
| EPS (Diluted) | $-0.49 | USD/shares | 2026-03-31 | 10-Q | 2026-04-21 |